Join
Live feed
·
PRReleasevia Quantisnow
Viatris Inc. logo
Pacira BioSciences Inc. logo

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTRS (Viatris Inc.), PCRX (Pacira BioSciences Inc.) and more on Quantisnow.